Skip to contentI
Intelligent Bio Solutions Inc.
I
INBSIntelligent Bio Solutions Inc. Q2 2023 · 10-Q
Revenue$356.68K$356.68K+100.6% vs Q2 2022 Net Income-$420.60K-$420.60KN/M vs Q2 2022 EPS Diluted-$5.56-$5.56N/M vs Q2 2022 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,380,850N/M Margins · derivedGross margin68.4%
Operating margin-597.4%+1352.4 pt vs Q2 2022
Net margin-117.9%+1828.2 pt vs Q2 2022
ended Dec 31, 2022 · filed Feb 14, 2023 · 45 d after period end